Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP807579.RAQr0-tpOmHkvFYU73L6NLKbMER9XJnr41QiqRAy7rPiM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP807579.RAQr0-tpOmHkvFYU73L6NLKbMER9XJnr41QiqRAy7rPiM130_assertion type Assertion NP807579.RAQr0-tpOmHkvFYU73L6NLKbMER9XJnr41QiqRAy7rPiM130_head.
- NP807579.RAQr0-tpOmHkvFYU73L6NLKbMER9XJnr41QiqRAy7rPiM130_assertion description "[This raises the question as to whether there is a subset of patients with skin cancer or AK lesions that are highly/more susceptible to local reactions caused by cyclo-oxygenase-2 (COX-2) inhibitors and peroxisome proliferator-activated receptor (PPAR) agonists?]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP807579.RAQr0-tpOmHkvFYU73L6NLKbMER9XJnr41QiqRAy7rPiM130_provenance.
- NP807579.RAQr0-tpOmHkvFYU73L6NLKbMER9XJnr41QiqRAy7rPiM130_assertion evidence source_evidence_literature NP807579.RAQr0-tpOmHkvFYU73L6NLKbMER9XJnr41QiqRAy7rPiM130_provenance.
- NP807579.RAQr0-tpOmHkvFYU73L6NLKbMER9XJnr41QiqRAy7rPiM130_assertion SIO_000772 17488409 NP807579.RAQr0-tpOmHkvFYU73L6NLKbMER9XJnr41QiqRAy7rPiM130_provenance.
- NP807579.RAQr0-tpOmHkvFYU73L6NLKbMER9XJnr41QiqRAy7rPiM130_assertion wasDerivedFrom befree-20140225 NP807579.RAQr0-tpOmHkvFYU73L6NLKbMER9XJnr41QiqRAy7rPiM130_provenance.
- NP807579.RAQr0-tpOmHkvFYU73L6NLKbMER9XJnr41QiqRAy7rPiM130_assertion wasGeneratedBy ECO_0000203 NP807579.RAQr0-tpOmHkvFYU73L6NLKbMER9XJnr41QiqRAy7rPiM130_provenance.